Advertisement

Topics

Q4 2017 EPS Estimates for Edwards Lifesciences Corporation (EW) Decreased by Leerink Swann

10:52 EDT 29 Jul 2017 | Topix

Edwards Lifesciences Corporation - Analysts at Leerink Swann reduced their Q4 2017 EPS estimates for shares of Edwards Lifesciences Corporation in a research note issued to investors on Thursday. Leerink Swann analyst D. Antalffy now expects that the medical research company will earn $0.88 per share for the quarter, down from their previous forecast of $0.89.

Original Article: Q4 2017 EPS Estimates for Edwards Lifesciences Corporation (EW) Decreased by Leerink Swann

NEXT ARTICLE

More From BioPortfolio on "Q4 2017 EPS Estimates for Edwards Lifesciences Corporation (EW) Decreased by Leerink Swann"

Quick Search
Advertisement